Purpose:The purpose of this study was to identify effects of symptom burden, self-efficacy, and stigma on cancer coping in patients with primary non-small cell lung cancer (NSCLC) undergoing chemotherapy.Methods: Data were collected from 140 patients receiving chemotherapy for NSCLC at the outpatient clinic of the respiratory department of a tertiary hospital in City B between February 3 and April 30, 2025.The data were analyzed using SPSS/WIN 28.0, and independent t-tests, one-way ANOVA, Pearson' s correlation coefficient, and hierarchical multiple regression analysis were applied.Results: Intrapersonal coping was found to be significantly correlated with symptom severity, symptom interference with daily life, stigma, and self-efficacy.Meanwhile, interpersonal coping was significantly correlated with symptom interference, stigma, and self-efficacy.Hierarchical regression analysis revealed that self-efficacy, symptom interference, and age were significant predictors of intrapersonal coping.In addition, marital status, selfefficacy, and stigma were identified as significant predictors of interpersonal coping.Conclusion: The findings highlight the importance of psychosocial and symptom-related factors, particularly self-efficacy, in supporting effective coping strategies among NSCLC patients undergoing chemotherapy.Tailored interventions that enhance self-efficacy and address stigma and symptom management may contribute to improved coping outcomes.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: